Avid Bioservices Inc
NASDAQ:CDMO
Avid Bioservices Inc
EPS (Diluted)
Avid Bioservices Inc
EPS (Diluted) Peer Comparison
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Avid Bioservices Inc
NASDAQ:CDMO
|
EPS (Diluted)
$0
|
CAGR 3-Years
-214%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
14%
|
|
Abbvie Inc
NYSE:ABBV
|
EPS (Diluted)
$2
|
CAGR 3-Years
0%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
1%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
EPS (Diluted)
$0
|
CAGR 3-Years
18%
|
CAGR 5-Years
-39%
|
CAGR 10-Years
-18%
|
|
Amgen Inc
NASDAQ:AMGN
|
EPS (Diluted)
$7
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
1%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
EPS (Diluted)
$13
|
CAGR 3-Years
11%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
EPS (Diluted)
$33
|
CAGR 3-Years
-3%
|
CAGR 5-Years
10%
|
CAGR 10-Years
25%
|
See Also
What is Avid Bioservices Inc's EPS (Diluted)?
EPS (Diluted)
-0.3
USD
Based on the financial report for Jan 31, 2024, Avid Bioservices Inc's EPS (Diluted) amounts to -0.3 USD.
What is Avid Bioservices Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
14%
The average annual EPS (Diluted) growth rates for Avid Bioservices Inc have been -214% over the past three years , -23% over the past five years , and 14% over the past ten years .